Milrinone, a phosphodiesterase inhibitor, suppresses intimal thickening after photochemically induced endothelial injury in the mouse femoral artery

Atherosclerosis

Volumn 142, Issue 1, 1999, Pages 133-138

  Kondo, Kazunao ^a   Umemura, Kazuo ^a   Miyaji, Mitsuru ^a   Nakashima, Mitsuyoshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclic AMP; Intimal thickening; Phosphodiesterase inhibitor; Photochemical reaction; Vascular smooth muscle cell proliferation

Indexed keywords

BROXURIDINE; CYCLIC AMP; MILRINONE; PHOSPHODIESTERASE INHIBITOR;

ANIMAL CELL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD CLOT LYSIS; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM INJURY; ENZYME INHIBITION; FEMORAL ARTERY; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

ANIMALS; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMORAL ARTERY; MALE; MICE; MICE, INBRED ICR; MILRINONE; MUSCLE, SMOOTH, VASCULAR; PHOSPHODIESTERASE INHIBITORS; PHOTOCHEMISTRY; PLATELET AGGREGATION; ROSE BENGAL; THROMBOSIS; TUNICA INTIMA;

EID: 0032889872     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00203-2     Document Type: Article

References (31)

1. Umemura K., Nishiyama H., Kikuchi S., Kondo K., Nakashima M. Inhibitory effect of a novel orally active GP IIb/IIIa inhibitor, SC-54684A on intimal thickening in the guinea pig femoral artery. Thromb Haemost. 76(5):1996;799-806.
2. Ross R., Raines E.W., Bowen-Pope D.F. The biology of platelet-derived growth factor. Cell. 46:1986;155-169.
3. Wang X., Feuerstein G.Z., Clark R.K., Yue T.L. Enhanced leucocyte adhesion to interleukin-1 beta stimulated vascular smooth muscle cells is mainly through intercellular adhesion molecule-1. Cardiovasc Res. 28:1994;1808-1814.
4. Hirosumi J., Nomoto A., Ohkubo Y., Sekiguchi C., Mutoh S., Yamaguchi I. et al. Inflammatory responses in cuff-induced atherosclerosis in rabbits. Atherosclerosis. 64:1987;243-254.
5. Ross R. The pathogenesis of atherosclerosis - an update. New Engl J Med. 314:1986;488-500.
6. Nicholson C.D., Challiss R.A.J., Shahid M. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol Sci. 12:1991;19-27.
7. Ito M., Tanaka T., Saitoh M., Masuoka H., Nakano T., Hidaka H. Selective inhibition of cyclic AMP phosphodiesterase from various human tissues by milrinone, a potent cardiac bipyridine. Biochem Pharmacol. 37(10):1988;2041-2044.
8. 2+ uptake by human platelets. Eur J Pharmacol. 245:1993;67-73.
9. Rump A.F., Acar D., Klaus W. A quantitative comparison of functional and anti-ischaemic effects of the phosphodiesterase-inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts. Br J Pharmacol. 112(3):1994;757-762.
10. Lebedinsky Y., Nordstrom S.T., Aschoff S.E., Kapples J.F., O'Malley G.J., Kosley R.W. Jr. et al. Cardiotonic and coronary vasodilator responses to milrinone, forskolin, and analog P87-7692 in the anesthetized dog. J Cardiovasc Pharmacol. 19:1992;779-789.
11. 2 synthesis: an in vitro study. Thromb Res. 71:1993;227-236.
12. Hirata Y., Umemura K., Kondoh K., Uematsu T., Nakashima M. Experimental intimal thickening studies using the photochemically induced thrombosis model in the guinea-pig femoral artery. Atherosclerosis. 107:1994;117-124.
13. Kikuchi S., Umemura K., Kondo K., Saniabadi A.R., Nakashima M. Photochemically induced endothelial injury in the mouse as a screening model for inhibitors of vascular intimal thickening. Arterioscler. Throm. Vasc. Biol. 187:1998;1069-1078.
14. Saniabadi A. Photosensitisers and photochemical reactions. Nakashima M. A novel photochemical model for thrombosis research and evaluation of antithrombotic and thrombolytic agents. 1994;1-19 Churchill Livingstone, London.
15. Ip J.H., Fuster V., Badimon L., Taubman M., Badimon J., Cherebro J.H. Syndromes of accerelated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol. 15:1990;1667-1687.
16. Matsuno H., Uematsu T., Nagashima S., Nakashima M. Photochemically-induced thrombosis model in rat femoral artery and evaluation of effects of heparin and tissue-type plasminogen activator with use of this model. J Pharmacol Method. 25:1991;303-318.
17. 2 receptor antagonist, vapiprost in rat middle cerebral artery thrombosis model. Stroke. 24:1993;1077-1081.
18. Fukuchi M., Uematsu T., Araki S., Nakashima M. Photochemically induced thrombosis of the rat coronary artery and functional evaluation of thrombus formation by occurrence of ventricular arrhythmias. Arch Pharmacol. 346:1992;550-554.
19. Umemura K., Kouno Y., Matsuno H., Uematsu T., Nakashima M. A new model for photochemically induced thrombosis in the inner ear microcirculation and the use of hearing loss as a measure for microcirculatory disorders. Eur Arch Oto-Rhino-Laryngol. 248:1990;105-108.
20. Kikuchi S., Umemura K., Kondo K., Nakashima M. Tranilast, an anti-allergic drug, suppresses intimal hyperplasia after photochemically-induced endothelial injury in the spontaneously hypertensive rat. Eur J Pharmacol. 295:1996;221-227.
21. Miyazawa N., Umemura K., Kondo K., Nakashima M. Effects of pemirolast and tranilast on intimal thickening after arterial injury in the rat. J. Cardiovasc. Pharmacol. 30:1997;157-162.
22. 1 on intimal thickening following photochemically induced endothelial injury in the rat femoral artery. Atherosclerosis. 130:1997;11-16.
23. Kondo K., Umemura K., Ohmura T., Hashimoto H., Nakashima M. Suppression of intimal hyperplasia by a 5-lipoxygenase inhibitor, MK-886: studies with a photochemical model of endothelial injury. Thromb Haemost. 79:1998;635-639.
24. Rao G.N., Runge M.S. Cyclic AMP inhibition of thrombin-induced growth in vascular smooth muscle cells correlates with decreased JNK1 activity and c-Jun expression. J Biol Chem. 271(34):1996;20805-20810.
25. 1 and intracellular cAMP levels. Prostag Leukotr Ess. 54(2):1996;101-107.
26. Clowes A.W., Schwartz S.M. Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res. 56:1985;139-145.
27. Mooradian D.L., Fernandes B., Diglio C.A., Lester B.R. Angiopeptin (BIM23014C) inhibits vascular smooth muscle cell migration in vitro through a G-protein-mediated pathway and is associated with inhibition of adenylyl cyclase and cyclic AMP accumulation. J Cardiovasc Pharmacol. 25(4):1995;611-618.
28. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
29. Derian C.K., Santulli R.J., Rao P.E., Solomon H.F., Barrett J.A. Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators. J Immunol. 154(1):1995;308-317.
30. Banner K.H., Moriggi E., Da Ros B., Schioppacassi G., Semeraro C., Page C.P. The effect of selective phosphodiesterase 3 and 4 isoenzyme inhibitors and established anti-asthma drugs on inflammatory cell activation. Br J Pharmacol. 119(6):1996;1255-1261.
31. Nielson C.P., Vestal R.E., Sturm R.J., Heaslip R. Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst. J Allergy Clin Immunol. 86:1990;801-808.